Filing Details

Accession Number:
0001140361-15-034627
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-08 19:42:23
Reporting Period:
2015-09-03
Filing Date:
2015-09-08
Accepted Time:
2015-09-08 19:42:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
943819 Resmed Inc RMD Surgical & Medical Instruments & Apparatus (3841) 980152841
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352232 Andrew Robert Douglas Resmed Inc.
9001 Spectrum Center Blvd.
San Diego CA 92123
President And Coo Resmed Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Resmed Common Stock Disposition 2015-09-03 500 $52.00 55,339 No 4 S Indirect Douglas Family Trust
Resmed Common Stock Acquisiton 2015-09-03 5,833 $19.25 61,172 No 4 M Indirect Douglas Family Trust
Resmed Common Stock Disposition 2015-09-03 5,833 $52.04 55,339 No 4 S Indirect Douglas Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Douglas Family Trust
No 4 M Indirect Douglas Family Trust
No 4 S Indirect Douglas Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Resmed Common Stock ResMed Common Stock Options Disposition 2015-09-03 5,833 $0.00 5,833 $19.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,336 2007-02-03 2016-02-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Resmed Common Stock 75,316 Direct
Footnotes
  1. The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
  2. Represents date options first became exercisable.
  3. This transaction was executed in multiple trades at prices ranging from $52.00 to $52.05. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.